Table 3.
Community dwelling [2, 28, 77, 78] | Hospitalized acute care [79–83] | Long-term care [84–88] | Hospice care [89, 90] |
---|---|---|---|
Abdominal pain | Comorbidities | Chewing problems | Cancer (e.g., trachea, bronchus, lung) |
BMI ≥ 25 | Acute exacerbation of COPD | Comorbidities | Dependence on caregivers |
Lower urinary tract symptoms | Cerebrovascular events | Arthritis | Insufficient food and fluid intake |
Medications | Chewing difficulties | Anorexia nervosa | Nonmalignant comorbidities |
Acetaminophen ≥7 tablets/week | Spinal cord lesions | CV disease | Circulatory |
Antiparkinsonian drugs | Medications | Cognitive impairment | Cardiac |
Aspirin or NSAIDs | Antimuscarinic drugs | Parkinson disease | Last pain score ≥ mild |
Diuretics | Antiparkinsonian drugs | Pneumonia | Respiratory |
Opioid analgesics | Diuretics | Postoperative pain (immobility) | Poor performance status |
Tricyclic antidepressants | Hypnotics | Presence of allergies | Toileting facilities (e.g., lack of privacy) |
Muscle relaxants | Decreased fluid intake (<5 glasses/day) | ||
NSAIDs | Dependence on caregivers | ||
Opioids | Inadequate dietary fiber | ||
Statins | Medications | ||
Antacids | |||
Acetaminophen | |||
Anticholinergic drugs | |||
Antidepressants | |||
Calcium channel antagonistsa | |||
Diuretics | |||
Histamine H2 receptor antagonists | |||
NSAIDs | |||
Opioid analgesics | |||
Polypharmacy (>5−7 drugs) | |||
Poor nutritional assessment | |||
Sedentary lifestyle | |||
Toileting facilities (e.g., lack of privacy) |
BMI body mass index, COPD chronic obstructive pulmonary disease, CV cardiovascular, NSAID nonsteroidal anti-inflammatory drug
aOther than verapamil and nifedipine